Cargando…
Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma
SIMPLE SUMMARY: Novel approaches to target RAS-signaling have led to the so called “RAS renaissance”. In HCC, it was demonstrated that wild-type RAS-RAF-ERK-signaling strongly contributes to HCC progression and drug resistance. In this context, microRNA-622 has emerged as one of the most promising t...
Autores principales: | Fritz, Valerie, Malek, Lara, Gaza, Anne, Wormser, Laura, Appel, Majken, Kremer, Andreas E., Thasler, Wolfgang E., Siebler, Jürgen, Neurath, Markus F., Hellerbrand, Claus, Bosserhoff, Anja K., Dietrich, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967205/ https://www.ncbi.nlm.nih.gov/pubmed/33803354 http://dx.doi.org/10.3390/cancers13051183 |
Ejemplares similares
-
Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11
por: Gaza, Anne, et al.
Publicado: (2021) -
Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma()
por: Dietrich, Peter, et al.
Publicado: (2019) -
Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma
por: Seitz, Tatjana, et al.
Publicado: (2020) -
Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” option
por: Dietrich, Peter, et al.
Publicado: (2017) -
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
por: Freese, Kim, et al.
Publicado: (2019)